TCL Archive Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority September 14, 1979
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014